Viewing Study NCT02872818



Ignite Creation Date: 2024-05-06 @ 8:59 AM
Last Modification Date: 2024-10-26 @ 12:08 PM
Study NCT ID: NCT02872818
Status: COMPLETED
Last Update Posted: 2016-08-23
First Post: 2016-08-16

Brief Title: Apoptotic Signaling Pathways in Rats With Endometrial Hyperplasia
Sponsor: Kayseri Education and Research Hospital
Organization: Kayseri Education and Research Hospital

Study Overview

Official Title: The Effect of Metformin and Medroxyprogesterone Acetate on Apoptotic Signaling Pathways in Wistar-Albino Rats With Induced Endometrial Hyperplasia
Status: COMPLETED
Status Verified Date: 2016-08
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The purpose of the study is to determine apoptotic signaling pathways such as Survivin Bcl-2 Bax c-Myc and caspase-9 expression levels in rats model with iatrogenic endometrial hyperplasia after metformin and medroxyprogesterone acetate administration
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None